Leiden (The Netherlands, 01.07.2021) – As of 1 July 2021, the Supervisory Board of the HAL Allergy Group has appointed Alex Huybens as Chief Executive Officer (CEO) and Member of…Lees verder
HAL Allergy S.r.l. and Avalon Counseling start telephone counseling to support doctors and medical personnel in the regions most affected by coronavirus
Telephone counseling for all hospital staff members in the regions of Lombardy, Emilia Romagna, Veneto, Piedmont Rome, Italy, (March 26, 2020) – Today, HAL Allergy S.r.l. announced the start of…Lees verder
Dr. Hans van Schijndel appointed as Chief Research & Development Officer of HAL Allergy Holding B.V.
Dear all, We are very pleased to announce that the Supervisory Board has appointed Dr. Hans van Schijndel as Member of the Board of HAL Allergy Holding B.V. in the…Lees verder
HAL Allergy first company to achieve marketing authorisations in line with Therapieallergene-Verordnung (TAV) in Germany
Registration of SUBLIVAC® Birch and SUBLIVAC® Trees 40.000 AUN/ml in Germany accomplished Leiden, the Netherlands (14 August 2018) – HAL Allergy B.V. today announced the registration of SUBLIVAC® Birch 40.000 AUN/ml and SUBLIVAC® Trees 40.000 AUN/ml…Lees verder